190PDResearch-based PAM50 predicts risk of relapse in...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

190PDResearch-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies

Bianchini, G, Parker, J, Carey, L, Perou, C M, Sica, L, Prat, A, Pieńkowski, T, Im, Y-H, Bianchi, G V, Ling-Ming, T, Liu, M-C, Lluch, A, Semiglazov, V, de la Haba-Rodriguez, J, Oh, D-Y, Poirier, B, Pe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy270.187
Date:
October, 2018
File:
PDF, 80 KB
english, 2018
Conversion to is in progress
Conversion to is failed